Enhancement of exposure therapy in participants with specific phobia: A randomized controlled trial comparing yohimbine, propranolol and placebo
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND Recent research indicates that pharmacological agents may enhance psychotherapeutic outcome. Yet, empirical results have not been conclusive with respect to two pharmacological agents, yohimbine hydrochloride (YOH) and propranolol. YOH is suggested to enhance emotional memory by elevating norepinephrine, whereas the β-adrenergic receptor antagonist propranolol might help better cope with feared situations by reducing accompanying bodily sensations. METHODS In this controlled trial, fifty-six participants with specific phobia were randomly assigned to either 1) virtual reality exposure therapy (VRET) plus YOH, 2) VRET plus Propranolol, or 3) VRET plus placebo. Participants in all conditions received three sessions of VRET over a period of two weeks. RESULTS We conducted 2 × 3 repeated measures MANOVA's. Results showed a significant effect for time, with partial eta squared ranging from ηp2 = 0.647 to ηp2 = 0.692, for specific phobia, yet no significant interaction effects were found. CONCLUSION No significant differences were found when VRET with YOH or a beta-blocker was compared to VRET with a non-active placebo. Implications for clinical practice and future research are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples
Brown, T. A., Chorpita, B. F., Korotitsch, W., & Barlow, D. H. (1997) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(96)00068-x · Cited by 1,860
Lobbestael, J., Leurgans, M., & Arntz, A. (2011) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.693 · Cited by 1,124 · cited 1×
“The SCID-I is a widely used diagnostic instrument for Axis I disorders (First, Spitzer, Gibbon & Williams, 1996) and has a good inter-rater reliability of axis I disorders (Lobbestael, Leurgans, & Arntz, 2011).”
Virtual reality exposure therapy for anxiety disorders: A meta-analysis
Powers, M. B., & Emmelkamp, P. M. G. (2008) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2007.04.006 · Cited by 904
Self-citationUnderstanding how and why psychotherapy leads to change
Kazdin, A. E. (2009) · Psychotherapy Research · doi:10.1080/10503300802448899 · Cited by 728 · cited 1×
“This might be an indication that a possible ceiling e ff ect of exposure (Kazdin, 2008) might explain the lack of any positive augmentation e ff ect in this study.”
Virtual reality exposure therapy in anxiety disorders: a quantitative meta-analysis
Opriş, D., Pintea, S., García-Palacios, A., Botella, C., Szamosközi, Ş., & David, D. (2012) · Depression and Anxiety · doi:10.1002/da.20910 · Cited by 636 · cited 2×
“Research has revealed strong support for the e ffi cacy of VRET for fear of fl ying and acrophobia (e.g. Meyerbröker, 2014; Meyerbröker & Emmelkamp, 2010; Opris et al., 2012; Powers & Emmelkamp, 2008), with e ff ects generalizing to daily life (Morina, Ijntema, Meyerbröker, & Emmelkamp, 2015).”
Brunet, A., Orr, S. P., Tremblay, J., Robertson, K., Nader, K., & Pitman, R. K. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.05.006 · Cited by 548
Morina, N., Ijntema, H., Meyerbröker, K., & Emmelkamp, P. M. G. (2015) · Behaviour Research and Therapy · doi:10.1016/j.brat.2015.08.010 · Cited by 439 · cited 1×
“Research has revealed strong support for the e ffi cacy of VRET for fear of fl ying and acrophobia (e.g. Meyerbröker, 2014; Meyerbröker & Emmelkamp, 2010; Opris et al., 2012; Powers & Emmelkamp, 2008), with e ff ects generalizing to daily life (Morina, Ijntema, Meyerbröker, & Emmelkamp, 2015).”
Self-citationSalivary alpha amylase as marker for adrenergic activity during stress: Effect of betablockade
van Stegeren, A., Rohleder, N., Everaerd, W., & Wolf, O. T. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.05.012 · Cited by 419
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390 · cited 1×
“…therapy to enhance treatment outcome by augmenting extinction learning and by disrupting reconsolidation of fear memory (Holmes & Quirk, 2009; Hofmann, Fang, & Gutner, 2014; Hofmann, Mundy, & Curtiss, 2015; McGuire, Lewin, & Storch, 2014; Singewald, Schmuckemair, Whittle, Holmes, & Ressler, 2015).”
Meyerbröker, K., & Emmelkamp, P. M. G. (2010) · Depression and Anxiety · doi:10.1002/da.20734 · Cited by 290
Self-citation
Cited by
Virtual reality therapy in mental health
Emmelkamp, P. M. G., & Meyerbröker, K. (2021) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-081219-115923 · Cited by 363
Self-citationVirtual reality in the diagnostic and therapy for mental disorders: A systematic review
Wiebe, A., Kannen, K., Selaskowski, B., Mehren, A., Thöne, A.-K., Pramme, L., Blumenthal, N., Li, M., Asché, L., Jonas, S., et al. (2022) · Clinical Psychology Review · doi:10.1016/j.cpr.2022.102213 · Cited by 223
Virtual reality therapy in social anxiety disorder
Emmelkamp, P. M. G., Meyerbröker, K., & Morina, N. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-01156-1 · Cited by 150
“While the effects of yohimbine have been investigated more extensively in other anxiety disorders and also in VRET with specific phobias [39], research into the effects of yohimbine in the treatment of SAD is scarce.”
BackgroundSelf-citationCausal interactive links between presence and fear in virtual reality height exposure
Gromer, D., Reinke, M., Christner, I., & Pauli, P. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.00141 · Cited by 127
Recent developments in the intervention of specific phobia among adults: a rapid review
Thng, C., Lim-Ashworth, N., Poh, B., & Lim, C. G. (2020) · F1000Research · doi:10.12688/f1000research.20082.1 · Cited by 31
Metadata
- Authors
- Meyerbröker, K., Morina, N., & Emmelkamp, P. M. G.
- Venue
- Journal of Anxiety Disorders
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 57
- Pages
- 48-56
- ISSN
- 0887-6185 (ISSN-L)
- OpenAlex
- W2800005992
- Cited by
- 34
- References
- 17
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhancement of exposure therapy in participants with specific phobia: A randomized controlled trial comparing yohimbine, propranolol and placebo. https://app.cochat.ai/papers/10.1016/j.janxdis.2018.05.001
- The paper
- Meyerbröker, K., Morina, N., & Emmelkamp, P. M. G. (2018). Enhancement of exposure therapy in participants with specific phobia: A randomized controlled trial comparing yohimbine, propranolol and placebo. Journal of Anxiety Disorders. https://doi.org/10.1016/j.janxdis.2018.05.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.